- Research works
- 52 ▼ 5% vs 2013–17
- Citations
- 1.1k 22.1 per fractional work
- Top-10% rate
- 22.5% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: German Inflammatory Bowel Diseases Study Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Arts and Humanities, 5.9×. Every wedge is a field page.
Which keywords describe research at German Inflammatory Bowel Diseases Study Group?
By fractional works in all years, weighted toward what it does more of than the world: Rituximab, PET Imaging, Lymphoma, Classification, Molecular Profiling, Prognostic Factors, Targeted Therapy and Chemotherapy.
- Survival
- Hedging
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Palbociclib
- Corporate Governance
- Radioimmunotherapy
- Cancer Treatment
- Epstein-Barr Virus
- Immunosuppression
- Cancer Incidence
- Methotrexate
- EGFR Mutations
- ALK Inhibitors
- Genomic Aberrations
- Therapeutic Targets
- Chemotherapy
- Prognostic Factors
- Classification
- PET Imaging
- Rituximab
- Lymphoma
- Molecular Profiling
- Targeted Therapy
- Radiotherapy
- Chronic Lymphocytic Leukemia
- Treatment Guidelines
- Clinical Trials
- Prognostic Scoring System
- Primary CNS Lymphoma
- Breast Cancer
- Dosimetry
- Kaposi's Sarcoma
- Metastatic Breast Cancer
- Radiopharmaceuticals
- CDK4/6 Inhibitors
- Pediatric Oncology
- Adaptive Reuse
- Derivatives
- Intangible Heritage
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Rituximab16▲ 195×3 topics
- PET Imaging14▲ 122×2 topics
- Lymphoma13▲ 170×3 topics
- Classification12▲ 66×1 topic
- Molecular Profiling12▲ 201×1 topic
- Prognostic Factors6▲ 24×5 topics
- Targeted Therapy5▲ 47×5 topics
- Chemotherapy5▲ 13×12 topics
- Radiotherapy4▲ 19×8 topics
- Therapeutic Targets4▲ 30×4 topics
- Chronic Lymphocytic Leukemia4▲ 144×1 topic
- Genomic Aberrations4▲ 144×1 topic
- Treatment Guidelines4▲ 32×2 topics
- ALK Inhibitors3▲ 118×1 topic
- Clinical Trials3▲ 11×2 topics
- EGFR Mutations3▲ 118×1 topic
- Prognostic Scoring System3▲ 159×2 topics
- Methotrexate3▲ 365×1 topic
- Primary CNS Lymphoma3▲ 365×1 topic
- Cancer Incidence2▲ 26×2 topics
- Breast Cancer2▲ 12×5 topics
- Immunosuppression2▲ 28×2 topics
- Dosimetry2▲ 34×2 topics
- Epstein-Barr Virus2▲ 103×1 topic
- Kaposi's Sarcoma2▲ 103×1 topic
- Cancer Treatment2▲ 11×2 topics
- Metastatic Breast Cancer2▲ 44×2 topics
- Radioimmunotherapy1▲ 67×1 topic
- Radiopharmaceuticals1▲ 67×1 topic
- Corporate Governance1▲ 4.1×2 topics
- CDK4/6 Inhibitors1▲ 131×1 topic
- Palbociclib1▲ 131×1 topic
- Pediatric Oncology1▲ 39×2 topics
- Acute Lymphoblastic Leukemia1▲ 55×1 topic
- Adaptive Reuse1▲ 68×1 topic
- Childhood Cancer1▲ 55×1 topic
- Derivatives1▲ 32×1 topic
- Hedging1▲ 130×1 topic
- Intangible Heritage1▲ 68×1 topic
- Survival1▲ 15×3 topics
Which research topics does German Inflammatory Bowel Diseases Study Group publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Cultural Heritage Management and Preservation, Lung Cancer Treatments and Mutations and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 2 Cultural Heritage Management and Preservation Archeology 1 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 4 Cancer Genomics and Diagnostics Cancer Research 0 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 7 Healthcare Policy and Management Economics and Econometrics 0 works
- 8 Socioeconomic Development in MENA Sociology and Political Science 0 works
- 9 Patient Satisfaction in Healthcare General Health Professions 0 works
- 10 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has German Inflammatory Bowel Diseases Study Group's research output changed?
Output in 2018–2022 was 5% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kiel
- Christian-Albrechts-Universität zu Kiel
- University Hospital Schleswig-Holstein
- GEOMAR Helmholtz Centre for Ocean Research Kiel
- Clinical Research Center Kiel
- Hochschule für Angewandte Wissenschaften Kiel
- Kiel Institute for the World Economy
- Leibniz Institute for Science and Mathematics Education
- Schmerzklinik Kiel
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.